Search research articles
Contact Us
Filters
Showing results (1-10 of 85) with videos related to
Page
of 9
Sort By:
Endocrinology and Metabolism Clinics of North America
|
April 18, 2003
Calcitonin
Stuart L Silverman
Rheumatic Diseases Clinics of North America
|
October 26, 2011
Osteoporosis
Stuart L Silverman
Current Osteoporosis Reports
|
September 3, 2009
New therapies for osteoporosis: zoledronic acid, bazedoxifene, and denosumab
Stuart L Silverman
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
October 8, 2008
Paget disease of bone: therapeutic options
Stuart L Silverman
Annals of the New York Academy of Sciences
|
October 16, 2010
Bisphosphonate use in conditions other than osteoporosis
Stuart L Silverman
Current Osteoporosis Reports
|
December 17, 2010
Defining zoledronate's duration of action and optimal dosing interval for an effective therapy
Stuart L Silverman
Journal of Osteoporosis
|
October 29, 2010
Sclerostin
Stuart L Silverman
Current Osteoporosis Reports
|
February 26, 2009
Zoledronic acid reduces recurrent clinical fracture in patients with hip fracture
Stuart L Silverman
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 15, 2009
Lessons from osteoporosis clinical trials
Stuart L Silverman
Annals of the New York Academy of Sciences
|
December 7, 2007
Selecting patients for osteoporosis therapy
Stuart L Silverman
Page
of 9
Search research articles
Search
Showing results (1-10 of 85) with videos related to
Sort By:
Page
of 9
Endocrinology and Metabolism Clinics of North America
|
April 18, 2003
Calcitonin
Stuart L Silverman
Rheumatic Diseases Clinics of North America
|
October 26, 2011
Osteoporosis
Stuart L Silverman
Current Osteoporosis Reports
|
September 3, 2009
New therapies for osteoporosis: zoledronic acid, bazedoxifene, and denosumab
Stuart L Silverman
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
October 8, 2008
Paget disease of bone: therapeutic options
Stuart L Silverman
Annals of the New York Academy of Sciences
|
October 16, 2010
Bisphosphonate use in conditions other than osteoporosis
Stuart L Silverman
Current Osteoporosis Reports
|
December 17, 2010
Defining zoledronate's duration of action and optimal dosing interval for an effective therapy
Stuart L Silverman
Journal of Osteoporosis
|
October 29, 2010
Sclerostin
Stuart L Silverman
Current Osteoporosis Reports
|
February 26, 2009
Zoledronic acid reduces recurrent clinical fracture in patients with hip fracture
Stuart L Silverman
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 15, 2009
Lessons from osteoporosis clinical trials
Stuart L Silverman
Annals of the New York Academy of Sciences
|
December 7, 2007
Selecting patients for osteoporosis therapy
Stuart L Silverman
Page
of 9